SCHOTT PHARMA AG & CO. KGAA

Press Releases SCHOTT Pharma AG & Co. KGaA

Equities

1SXP

DE000A3ENQ51

Real-time Estimate Tradegate Other stock markets 09:33:42 30/05/2024 BST			5-day change	1st Jan Change
28.4 ^EUR	-0.49%		-7.45%	-15.71%

05-28	SCHOTT PHARMA : Berenberg reiterates its Neutral rating	ZD
05-21	Deutsche Bank Research lowers target for Schott Pharma - 'Buy'	DP

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

SCHOTT Pharma AG & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	05-23	EQ
SCHOTT Pharma AG & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	05-23	EQ
SCHOTT Pharma AG & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	05-17	EQ
SCHOTT Pharma AG & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	05-17	EQ
SCHOTT Pharma confirms outlook for FY 24 based on Q2 results; FY 25 impacted by slower growth from syringes	05-14	EQ
SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma see FY 25 impacted by slower growth from syringes	05-14	EQ
SCHOTT Pharma appoints Tobias Erfurth as Head of Investor Relations	04-30	EQ
SCHOTT Pharma to Expand in the U.S. with New Prefillable Syringe Manufacturing Facility in Wilson, North Carolina	03-19	AQ
SCHOTT Pharma to Expand in the U.S. with New Prefillable Syringe Manufacturing Facility	03-18	EQ
Successful 2024 Annual General Meeting of SCHOTT Pharma: Shareholders approve all items on the agenda	03-14	EQ
DD: SCHOTT Pharma AG & Co. KGaA: Dr. Jens Schulte, sell	03-04	EQ
SCHOTT Pharma reports good start into fiscal year 2024	02-29	EQ
AFR: SCHOTT Pharma AG & Co. KGaA: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements	02-26	EQ
SCHOTT Pharma delivers on 2023 targets and continues profitable growth trajectory	01-26	EQ
AFR: SCHOTT Pharma AG & Co. KGaA: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]	01-15	EQ
SCHOTT Pharma delivers right after IPO with strong profitable growth for the full year, at the upper end of its guidance	12-19	EQ
Hello SDAX! SCHOTT Pharma reaches next milestone as a publicly listed company	12-06	EQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

fermer